Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Diffusion Pharmaceuticals Inc.Financial_Report.xls
EX-4.6 - EX-4.6 - Diffusion Pharmaceuticals Inc.a15-2678_1ex4d6.htm
EX-4.4 - EX-4.4 - Diffusion Pharmaceuticals Inc.a15-2678_1ex4d4.htm
EX-4.5 - EX-4.5 - Diffusion Pharmaceuticals Inc.a15-2678_1ex4d5.htm
EX-31.1 - EX-31.1 - Diffusion Pharmaceuticals Inc.a15-2678_1ex31d1.htm
EX-32.2 - EX-32.2 - Diffusion Pharmaceuticals Inc.a15-2678_1ex32d2.htm
EX-32.1 - EX-32.1 - Diffusion Pharmaceuticals Inc.a15-2678_1ex32d1.htm
EX-10.7 - EX-10.7 - Diffusion Pharmaceuticals Inc.a15-2678_1ex10d7.htm
EX-10.12 - EX-10.12 - Diffusion Pharmaceuticals Inc.a15-2678_1ex10d12.htm
EX-10.13 - EX-10.13 - Diffusion Pharmaceuticals Inc.a15-2678_1ex10d13.htm
10-K - 10-K - Diffusion Pharmaceuticals Inc.a15-2678_110k.htm
EX-31.2 - EX-31.2 - Diffusion Pharmaceuticals Inc.a15-2678_1ex31d2.htm

Exhibit 21.1

 

SUBSIDIARIES OF THE REGISTRANT

 

Name of Subsidiary

 

State or Other Jurisdiction
of Incorporation or
Organization

 

Direct or Indirect
Ownership Interest by
RestorGenex

 

Canterbury Laboratories, LLC

 

DE

 

100

%

Hygeia Therapeutics, Inc.

 

DE

 

100

%

Paloma Pharmaceuticals, Inc.

 

DE

 

100

%

VasculoMedics, Inc.

 

DE

 

100

%